GHK-Cu: Identity and Evidence Boundaries

Scope of this reference

This page concerns the catalogue identity of GHK-Cu as a laboratory material and the boundaries of what published evidence and batch analysis establish. It is not a treatment guide, a recommendation, a cosmetic-use guide, a human-use protocol or evidence that the material is safe or effective in people or animals.

What GHK-Cu is

GHK-Cu is a tripeptide — glycyl-L-histidyl-L-lysine — in complex with a copper(II) ion. Two components of the name carry identity information:

• •GHK is the three-residue peptide sequence.
• •Cu indicates that the material is supplied as a copper complex, not as the bare peptide.

The copper is coordinated to the peptide rather than merely present alongside it, and that complex is what the name denotes. It is also why solutions of the material are visibly coloured, which is a property of copper coordination chemistry rather than an indicator of activity or quality.

The listed material is GHK-Cu, in the copper and skin collection.

"Copper peptide" is not one thing

The phrase copper peptide is generic. It covers several chemically distinct molecules, including GHK-Cu and AHK-Cu, and in cosmetic ingredient nomenclature the name *copper tripeptide-1* is also used for the GHK complex.

Conflating these is the most common factual error in descriptions of this material. Three practical consequences:

• •Literature on one copper peptide is not literature on another.
• •An ingredient-nomenclature name and a research-catalogue name may refer to the same complex, but neither name establishes equivalence of grade, purity or intended use.
• •The spellings *GHK-Cu* and *ghkcu* denote one material, not two.

Reading the evidence by tier

• •In-vitro — assays, cell lines and isolated tissue. Establishes behaviour in that system only.
• •Animal models — establishes findings in that species under those conditions.
• •Human data — the tier where claims about people could be grounded.

For GHK-Cu the published record is overwhelmingly in-vitro and animal. Much of it concerns gene-expression and extracellular-matrix observations in cultured cells. Those are findings about cell systems; presenting them as demonstrated outcomes in people misrepresents the source, and the volume of citations does not change the tier they sit in.

What analytical documentation establishes

A certificate of analysis provides evidence about the particular batch tested — its identity, measured composition and purity by the stated method. It does not establish a biological, therapeutic, cosmetic or physiological outcome, and it does not extend to other batches.

For a metal complex there is an additional question worth checking: whether a stated mass refers to the peptide, the complex, or the peptide corrected for copper content. Available reports are published in our COA library; the guides to reading a peptide COA and understanding HPLC purity explain what those documents can and cannot show.

Laboratory-use boundary

Materials sold on this site are supplied solely for non-clinical in-vitro laboratory research. They must not be ingested, injected, inhaled, applied or otherwise administered to a human or animal.

We do not provide dosing, routes of administration, treatment guidance, cosmetic-use guidance or in-vivo protocols. Preparation, storage and handling must follow a validated institutional SOP, the material documentation and an appropriate risk assessment.